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Abstract
There is an increasing interest in the use of
Complementary and Integrative Health (CIH) for
treatment of pain as an alternative to opioid
medications. We use a novel explainable deep learning
approach compared and contrasted to a traditional
logistic regression model to explore the impact of
musculoskeletal disorder related factors on the use of
CIH. The impact scores from the neural network show
high correlation with the log-odds ratios of the logistic
regression, showing the promise that neural networks
can be used to identify high impact factors without
depending on a priori assumptions and limitations of
traditional statistical models.

1. Introduction
There is increasing interest in the use of
Complementary and Integrative Health (CIH)
approaches for pain as an alternative to opioid
medications. Opioid misuse, abuse, addiction, and
overdose are a worldwide public health crisis [1]. In the
US, opioid prescription-related deaths have quadrupled
since 1999, and are a leading cause of death today [2].
While men are more likely to die from opioid overdose
than women, that gap is closing [2]. Patients with mental
health and substance use disorders, in particular those
with post-traumatic stress disorder (PTSD), have higher
rates of opioid-related morbidity and mortality [3, 4].
Currently, there is intense interest in alternatives to
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opioids for treating pain [5-7]. However, there is an
urgent need to identify interventions that can reduce
opioid initiation, without increasing harms, and to
identify factors associated with their utilization.
The Institute of Medicine (IOM) noted that a large
and growing array of evidence-based CIH including
acupuncture, massage, meditation, and yoga, among
others, may hold special appeal to persons with pain [8].
CIH has been used for pain and a number of other
conditions [9]. Results from a survey of Veterans with
chronic non-cancer pain (N=401) indicated that 82%
reported some prior CIH use, and 99% a willingness to
try it [10]. According to another recent study, Operation
Enduring Freedom (OEF)/Operation Iraqi Freedom
(OIF)/Operation New Dawn (OND) Veterans, women,
and younger Veterans are more likely to use CIH [11].
Although studies directly comparing CIH and
opioids are lacking [12], recent systematic reviews
reveal that when compared to a common control group
of usual care, the CIH modalities to be studied here have
a similar magnitude of pain improvement [13-18].
However, the evidence base regarding the impact of
CIH on opioid use is limited. “No study to date has
evaluated the effectiveness of select CIH interventions
for reducing opioid initiation, or for reducing opioid or
stopping use.” [19]
Our team has been conducting a larger project that
aims to study the effect of CIH use on pain management
including opioid use and whether the effect varies by
demographic and/or clinical characteristics. As part of
the project, we set out to identify characteristics
associated with the utilization of CIH in patients with
chronic pain, employing both deep learning and logistic
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regression approaches. Logistic regression is commonly
used in clinical and health services research, though it
makes some assumptions: a linear relationship between
the logit of the outcome and predictor variables, no
extreme values or outliers in the continuous predictors
and no high intercorrelations among the predictor
variables. Deep learning, like many machine learning
algorithms, does not make such assumptions and is
capable of modeling non-linear relationships.
Furthermore, we have been developing an explainable
artificial intelligence (AI) method called Impact
Assessment (IA) that allows the use of deep learning to
study factors, including patient demographic and
clinical characteristics as well as facility attributes, that
are associated with the use of CIH.
We have used Veteran Affairs (VA) Electronic
Health Record (EHR) data in the analysis. VA is the
largest integrated healthcare system in the US and a
leader in quality and efficiency due in part to the
transformation of its EHR [20-22]. Most EHR data are
in readily analyzable structured data fields (e.g. weight,
stop codes, ICD, and CPT codes) [21]. However, many
services do not have CPT or ICD codes, and CIH receipt
may be detailed in clinical notes [23]. Structured data
alone are insufficient to identify CIH use [24]. For
example, patients may obtain CIH from non-VA
providers, particularly when a specific therapy is not
available at a local VA facility. However, VA providers
often document them in clinical notes. In this work, we
developed a natural language processing tool to extract
CIH use from clinical notes with area under the curve
(AUC) ranging from 82.8% to 91.8%, depending on the
CIH modalities.

2. Methods
2.1 Dataset and CIH Extraction
We used data from the VA Musculoskeletal
Disorders (MSD) Cohort, developed by Goulet et al
[25]. The cohort contains data on patients with back,
neck, and large joint disorder diagnoses. The key
domains and sample variables in the MSD cohort are
shown in Table 1.
To extract the CIH utilization documented in clinical
notes of members of the MSD cohort, we annotated a
random sample of clinical notes from the VA EHR
stored in the Veterans Administration Informatics and
Computing Infrastructure (VINCI) database. A team of
clinical experts defined a list of CIH-related keywords
for different CIH modalities, which was used to identify
CIH-related notes. For example, for acupuncture the
keywords were “acupuncture”, “ACUP”, and
“needling”. From CIH-related notes, snippets

Table 1. Key domains and example variables
contained in the MSD cohort.
Domain
Variables
Demographics
DOB, race/ethnicity, sex,
service-connected status,
service era
Diagnoses
Specific MSD(s), PTSD,
substance use disorders, etc.
Procedures
CPT and ICD, including for
CIH
Vitals
Pain intensity NRS scores, BP,
height/weight
Consults &
Specialty pain clinic, opioid
referrals
substitution therapy (e.g.
methadone)
Pharmacy
Opioids, tramadol, gabapentin,
antidepressants,
benzodiazepines
Health screening Smoking, alcohol, PTSD, and
depression screen results
Laboratory data Urine drug test, liver function
test, and pathology results
Risk factors
Prior overdose or suiciderelated event
Treatment
Mental health clinic stop codes
composed of the keywords together with 30 words
before and 30 words after were extracted. We chose 30
words in response to experience in previous studies on
the same EHR data set [26, 27, 28, 29]. The snippets
were categorized into 6 modalities: Acupuncture,
Biofeedback, Guided Imagery [30], Meditation, Tai-Chi
and Yoga. For each modality, a small subset
(n=500~600) of the snippets was selected for human
annotation. The human annotated data were then used to
develop, train and test NLP classifiers.
An annotation guideline was developed and
iteratively refined through group chart review. The
annotation
labels
were
“current
user,”
“planned/recommended,” “uncertain,” “past user,” and
“none-user.” We further grouped the original multiple
category annotation labels into binary labels: “current
user” (positive) vs. “all other cases” (negative). “Current
user” means that the snippet shows a patient was a
current CIH user at the time when the note was written.
The annotation was first performed by a dedicated
annotator and subsequently reviewed according to the
guideline and revised by 2 other team members.
Questions and disagreements were resolved by
consensus.
We first tokenized the snippets by converting all
upper-case characters to lower case and removing all
punctuation and numbers. We then generated both 1gram and 2-gram bag of words features. The 1-gram
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features were unique words and 2-gram features were
two adjacent words that were originally (i.e., before
removing punctuations and numbers) separated by only
white spaces. Because of the large number of 2-gram
features, we selected 2-grams based on their
discriminative power.
We trained support vector machine (SVM) models
to classify the snippets. After experimenting with
several other kernels such as a polynomial kernel, we
selected a linear kernel as it yielded the best
performance. We used 10-fold cross validation to
measure the classification performance, i.e. splitting the
annotated data into 10 subsets, using 9 subsets for
training and 1 subset for testing, and repeating the
process 10 times.
We calculated performance metrics including area
under the receiver operating characteristics curve
(AUC) and accuracy, with AUC being the primary
metric and accuracy a secondary metric. The SVM
classifiers were optimized for AUC in all experiments.
The final performances were micro-averaged over the
10-folds for each metric. The AUC ranged from 82.8%
to 91.8% (Table 2).
In all, 26,769,725 document snippets having CIH
keywords were identified from 17,072,822 distinct
documents, belonging to 15,095,504 visits, in turn
representing 2,283,936 individual patients. We
randomly sampled 10,000 patients to study the
demographic and clinical factors associated with CIH
use. Characteristics of the patients are presented in
Table 3.
We selected 19 variables in 5 categories as
predictors (Table 4). These represented demographics
(age and gender), race/ethnicity, vitals (pain, body mass
index (BMI)), comorbidities (post-traumatic stress
disorder (PTSD), major depressive disorder (MDD),
bipolar disorder, anxiety disorder, hypertension,
coronary artery disease (CAD), and Charlson
comorbidity index (CCI)), behaviors (drug use disorder,
alcohol use disorder, and smoking history), and
analgesic use (opioid and non-opioid). The variables
were selected based on their high prevalence among
Veterans in VHA care, and their known or hypothesized
association with CIH.
Data was aggregated by patient, with age calculated
as the average of each patient’s age at the time of the
visits corresponding to the sampled documents.
Analgesic use was determined by counting the number
of filled opioid or non-opioid analgesic prescriptions for
a patient, where the prescription fill occurred within one
month prior to or following one of the CIH correlated
visits. 239 patients were excluded due to missing values
for multiple variables, resulting in 9,761 patients in the
analysis. In addition, 851 patients were missing BMI
values. These missing BMI values were assigned the

average of the BMI of the other patients in the analysis.
The final 9,761 patients randomly assigned to sets for
training (60%), validation (20%), and testing (20%).

2.2 Deep Neural Network
In order to identify characteristics associated with
the utilization of CIH, and to assess an alternative to
logistic regression, we chose to implement a Deep
Neural Network (DNN). However, a concern with DNN
methods is that they are viewed as black-boxes and are
Table 2. Performance metrics for CIH modality
classification.
Modality
AUC
Accuracy
Acupuncture
0.918
0.858
Biofeedback
0.864
0.804
Guided Imagery
0.910
0.854
Meditation
0.828
0.833
Tai-Chi
0.878
0.818
Yoga
0.856
0.798
Table 3. Demographics and clinical
characteristics of the patient sample
All Patients
9,761
Basic Demographics
Male
8,805 (90%)
Female
956 (10%)
Age: Mean, Median
57, 58
Race/Ethnicity
White
6,472 (66%)
Black
2,114 (22%)
Hispanic
615 (6%)
Other/Unknown
560 (6%)
Vitals
Pain: Mean, Median
3.9, 4
BMI: Mean, Median
29.2, 28.5
Comorbidities
PTSD
1,704 (17%)
MDD
1,012 (10%)
Bipolar Disorder
544 (6%)
Anxiety Disorder
1,134 (12%)
Hypertension
4,152 (43%)
CAD
1,182 (12%)
CCI: Mean, Median
0.68, 0
Drug Use Disorder
981 (10%)
Alcohol Use Disorder
1,533 (16%)
Smoking History
6,598 (68%)
Analgesic Use
Opioid
3,781 (39%)
Non-Opioid
3,704 (38%)
CIH Use
5,001 (51%)
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difficult to interpret, yet interpretability is critical for
clinical adoption of findings. One approach to explain
AI models is Local Interpretable Model-Agnostic
Explanations (LIME) [31]. The Impact Assessment
method we use is related to the LIME approach. We
have validated the Impact Assessment method by
comparing its results with odds ratios derived from
logistic regression, finding strong but not perfect
correlations as expected [32]. Another validation
approach is to use a dataset with known underlying
relationship between predictors and outcome. Since we
do not have the complete knowledge of underlying
relationships in real patient datasets, we experimented
with simulated datasets with 100 variables and a mixture
of linear and non-linear relationships. Noting that
simulated data are far less complex that real patient
datasets, we observed that the Impact Assessment is
highly accurate (90-95%) in estimating the contribution
of a variable to the outcome.

Outcome variable
CIH use
Predictors
Demographics
Age
Gender
Race/Ethnicity
White
Black
Hispanic
Vitals
Pain
BMI
Comorbidities
PTSD
MDD
Bipolar Disorder
Anxiety Disorder
Hypertension
CAD
CCI
Drug Use
Disorder
Alcohol Use
Disorder
Smoking History
Analgesic Use
Opioid
Non-opioid

In order to evaluate our Impact Assessment method
using real, non-simulated data, we built a DNN using
the CIH data from section 2.1. The DNN was
constructed with an input layer of 19 nodes,
corresponding to the 19 variables, and an output layer of
a single node using a sigmoid activation function giving
the probability of CIH use. Five fully connected hidden
layers were used, all using the rectified linear unit
function for activation. The number of nodes in the
hidden layers were 200, 300, 200, 300, and 200.
Weights were initialized with random small numbers
and updated using stochastic gradient descent with
Nesterov momentum. A mini-batch size of 100 was
used, along with a learning rate of 0.001 and a
momentum of 0.9. AUC was measured against the
validation set after each epoch. We used 150 epochs, at
which point no improvement in AUC was seen in the
last 10 epochs. The final DNN model was kept for
subsequent impact score measurements.

Table 4. CIH outcome and predictor variables
Variable
Representation
Type
Dichotomous 0 = No CIH use, 1 = at least one CIH use
Continuous
Dichotomous

Normalized to 0 – 1
0 = Male, 1 = Female

Dichotomous
Dichotomous
Dichotomous

0 = Non-White, 1 = White
0 = Non-Black, 1 = Black
0 = Non-Hispanic, 1 = Hispanic

Ordinal
Continuous

Normalized to 0 – 1
Normalized to 0 – 1

Dichotomous
Dichotomous
Dichotomous
Dichotomous
Dichotomous
Dichotomous
Ordinal
Dichotomous
Dichotomous

0 = no PTSD, 1 = PTSD
0 = no MDD, 1 = MDD
0 = no Bipolar, 1 = Bipolar
0 = no Anxiety, 1 = Anxiety
0 = no Hypertension, 1 = Hypertension
0 = no CAD, 1 = CAD
Normalized to 0 – 1
0 = no non-alcohol, non-tobacco drug abuse, 1 = non-alcohol, nontobacco drug abuse
0 = no Alcohol use, 1 = Alcohol use

Dichotomous

0 = no history of smoking, 1 = smoking history

Dichotomous
Dichotomous

0 = no opioid use, 1 = opioid use
0 = no non-opioid analgesic use, 1 = non-opioid analgesic use
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2.3 Impact Assessment
We define a new variable called impact score. For
each variable, a reference value is selected. For binary
variables such as diagnoses, 0 is viewed as the reference,
as it has been used to indicate the absence of a diagnosis.
For categorical variables (e.g. race), we select a category
(e.g. unknown) based on convention and clinical context
as the reference. For continuous variables, we use the
mean as the reference. To calculate the impact score for
a variable, we change its current value to the reference
value and observe change in the outcome. If the
outcome does not change, this suggests that the change
in value has no impact. If the model changes, the impact
score will be calculated as follows:
The last layer of the DNN outputs a value 𝑝 between
0 and 1 through a sigmoid function 𝑝 = 𝜎(𝑥). The
change of prediction originates from change in 𝑥. One
way to obtain 𝑥 from 𝑝 is the logit function:
𝑥 = logit(𝑝) = log

𝑝
1−𝑝

Therefore, the individual-level impact score is defined
as:
logit(𝑝cur ) − logit(𝑝ref )
(current value) − (reference value)
where: 𝑝ref is the new value of 𝑝 after changing the
current value to reference value. Note that the score is
only defined if the current value differs from the
reference value.
We define the impact score at the population level
simply as the mean of all impact scores of patients on
whom the score is defined. The Impact score can be
interpreted similarly to the log-odds ratio from logistic
regression. It represents the average rate of change of
log-odds of the predicted risk.

2.6 Logistic Regression
Logistic regression (LR) is often used to investigate
the relationship between discrete responses and
explanatory variables and is widely accepted in the
medical domain because it provides easy
explanation/interpretation for predictions. Specifically,
the log odds ratios describe the impact of the
corresponding variables on the predicted results.
Consider a dichotomous response variable such as CIH
use, absent (0) or present (1), and a vector of variable(s)
X that takes the value 1 if present and 0 if absent. The
odds ratio is defined as the ratio of the odds for those
with the variable=1 to the odds for those with
variable=0. The formula and underlying assumptions

for the odds ratio (e.g. sigmoid function) shares some
aspects with the impact assessment above, and is given
by:
𝑃
𝑙𝑛 9
; = 𝑎 + 𝑏𝑋
1−𝑃
The probability (P) can be computed from the
regression equation. So, if we know the regression
equation, we can calculate the expected probability that
Y = 1 for a given value of X.
𝑃=

𝑒 ABCD
1 + 𝑒 ABCD

We trained a logistic regression model as a
comparison to our DNN/Impact Score analysis. The
same source data was used as in DNN, but with an 80%20% Train-Test split. The Broyden-Fletcher-GoldfarbShanno (BFGS) solver was used.

2.7 Comparing DNN and Logistic Regression
To compare the DNN and Logistic Regression we
use 3 measures between the log-odds ratio of the logistic
regression and the impact score of the DNN. For an
overall performance measure, we calculated the Area
Under the Curve (AUC) of the Receiver Operating
Characteristics. We also calculated the Pearson
correlation to measure the amount of linear correlation,
and Spearman correlation to compare the rank orders.

3. Results
Logistic regression and DNN with impact scores
were performed on a dataset consisting of 19 variables
from 9,761 patients for prediction of CIH use. The
logistic regression required 83 iterations for
convergence and finished with an AUC of 0.6805. The
DNN impact scores are averages of 25 trainings of the
DNN using different random seeds, with an average
AUC of 0.7275. Details of the results are presented in
Table 5, showing the log-odds ratio and 95% confidence
interval for each variable of the logistic regression, and
impact score with 95% confidence interval for each
variable of the DNN. Correlation between the sets of
results are shown in Table 6, with a Pearson correlation
of 0.84 and Spearman correlation of 0.97.
To investigate the impact of variables that were not
significant according to the LR model, we repeated the
analysis with the non-significant variables excluded.
Variables with non-significant p-values were Opioid
Analgesics (p>0.008), Pain (p>0.909), Hypertension
(p>0.025), BMI (p>0.674), Smoking History (p>0.097)
and Hispanic (p>0.088). This resulted in increased
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Table 5. Comparison of Logistic Regression to DNN Impact Score, ordered by log-odds ratio
and impact score
Logistic Regression
DNN Impact Score
95% Conf Int

Drug Use Disorder

logodds
ratio
0.78

Impact
score

95% Conf Int

0.57

1.00

Drug Use Disorder

0.69

0.68

0.71

PTSD

0.73

0.59

0.86

PTSD

0.68

0.67

0.68

Alcohol Use Disorder

0.52

Gender (F)

0.50

0.36

0.69

Alcohol Use Disorder

0.52

0.51

0.53

0.34

0.67

Bipolar Disorder

0.49

0.48

0.50

MDD

0.47

0.30

0.65

Gender (F)

0.47

0.47

0.48

Bipolar Disorder

0.47

0.23

0.71

Non-Opioid Analgesics

0.47

0.46

0.47

Non-Opioid Analgesics
Black

0.46
0.41

0.36
0.22

0.56
0.60

MDD
Anxiety Disorder

0.28
0.27

0.27
0.26

0.28
0.28

Anxiety Disorder

0.28

0.12

0.44

Black

0.23

0.21

0.25

White

0.27

0.10

0.45

BMI

0.22

0.15

0.29

Hispanic

0.20

-0.03

0.44

Opioid Analgesics

0.13

0.12

0.13

Opioid Analgesics

0.14

0.04

0.24

Age

0.09

0.08

0.09

Smoking History

0.09

-0.02

0.19

White

0.08

0.07

0.10

Pain

0.01

-0.14

0.15

Smoking History

0.06

0.05

0.07

BMI

0.002

-0.01

0.01

Hispanic

0.03

0.00

0.05

Hypertension

-0.12

-0.23

-0.02

Pain

-0.07

-0.08

-0.06

CAD

-0.34

-0.50

-0.18

Hypertension

-0.17

-0.18

-0.17

Age

-1.35

-1.63

-1.06

CAD

-0.22

-0.22

-0.21

CCI

-1.75

-2.35

-1.15

CCI

-1.40

-1.46

-1.34

AUC = 0.6805
Table 6. Correlations between the logistic
regression log-odds ratios and the DNN
impact scores.
Pearson
Correlation
0.84
(linear correlation)
Spearman Correlation
0.97
(rank correlation)
Pearson correlation, but the other measures were
largely unchanged (LR AUC = 0.6821, DNN AUC =
0.7278; Pearson correlation = 0.98; Spearman
correlation = 0.96).

4. Discussion
We analyzed patient characteristics associated
with the utilization of complementary and integrative
health in patients with musculoskeletal disorders using

Ave. AUC = 0.7275
a novel explainable deep learning approach and a
traditional logistic regression approach. Both
approaches identified Drug Use Disorder, PTSD,
Alcohol Use Disorder, Gender (Female), MDD,
Bipolar Disorder, Opioid and Non-Opioid Analgesic
use, Race, and Anxiety Disorder as the characteristics
associated with increased CIH use. CCI, CAD, and
Hypertension were associated with decreased use of
CIH.
Importantly, the results from the two approaches
have some differences as well. Greater than average
BMI, Smoking History, and Hispanic race showed a
small association with increased CIH with the DNN
model but were indeterminate with the logistic
regression model due to its 95% confidence interval
crossing 0. Conversely, Pain had a small association
with decreased CIH in DNN but was not significant in
logistic regression. Interestingly, these small
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differences occurred in variables that had insignificant
p-values in the LR model.
The general agreement between the DNN impact
scores and the log odds ratios from LR reflect that both
models were trained on the same data. Because DNN
can have a variety of architectures and use different
random seeds, multiple DNN models may be trained
on a dataset. Combining the impact scores from
multiple DNN models allows us to calculate a
confidence interval for an impact score. Even though
we cannot directly compare an impact score’s
confidence interval with the confidence interval of log
odds ratio from the regression analysis, it does provide
a range of potential values for the impact score in
addition to the mean. The Pearson correlation and
Spearman correlation show that the results are highly
correlated both linearly and by rank order.
The goal of the analysis is NOT to predict CIH, but
to understand the relationship between patient
characteristics and CIH use. Since the decision to use
CIH is often influenced by non-clinical characteristics
such as provider or patient preference and availability
of CIH services, we did not expect the logistic
regression and DNN models to be able to predict CIH
use based on only patient characteristics. Consistent
with our expectation, the AUC for both logistic
regression and the DNN impact scores were too low to
be reliable.
The fact that the two different approaches arrive at
similar but modestly different conclusions is
intriguing. The novel DNN explanation method
provides an alternative means to determine the effect
of patient characteristics on CIH that does not depend
on a priori assumptions and limitations of traditional
statistical models. It can potentially detect novel and
unexpected types of associations that would have to be
decided upon in advance for traditional statistical
models, partly due to the ability of DNNs to model
non-linear relationships.
The points on which the two models agree imply
that CIH is more likely to be used by those with a
history of substance abuse and mental illness. This
may be the result of physicians being more reluctant in
prescribing opioids to those patients, resulting in more
use of CIH. Also, worth noting is the stronger
association of the use of non-opioid analgesics with
CIH use than the use of opioid analgesics with CIH
use.
An important limitation of this study is that CIH
use is not completely captured by EHRs. On the other
hand, based on our experience in CIH research,
missing data of CIH use is more random than
systematic. This limits the impact of the missing data
on our analysis. Socio-economic status may be an
important confounder and needs to be captured in

follow up studies. In addition, temporal characteristics
of the variables were not included in this analysis, such
as length of chronic pain.
Future work will incorporate a more nuanced study
of the relationships between opioid and other
treatment options. In this study all CIH modalities
were treated as one, however more knowledge is
obtainable by differentiating the CIH modalities. In
addition, patient and provider geographical location
can be incorporated in order to discover variances by
location, and also to incorporate socio-economic data
stratified by location.

5. Conclusion
In this study we have demonstrated the practicality
of a novel Impact Assessment method to interpret
DNN models, for the purpose of exploring factors
associated with utilization of CIH treatments among
patients with musculoskeletal disorders. The DNN and
logistic regression-based approaches arrived at similar
but modestly different conclusions, while DNN does
not depend on a priori assumptions and limitations of
traditional statistical models, and is able to represent
more complex, non-linear relationships.
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